Literature DB >> 16954333

Epithelial lining fluid free IGF-I-to-PAPP-A ratio is associated with bronchopulmonary dysplasia in preterm infants.

Ettore Capoluongo1, Franco Ameglio, Paola Lulli, Angelo Minucci, Concetta Santonocito, Paola Concolino, Enrico Di Stasio, Simona Boccacci, Valentina Vendettuoli, Giuseppe Giuratrabocchetta, Angela De Cunto, Milena Tana, Costantino Romagnoli, Cecilia Zuppi, Giovanni Vento.   

Abstract

Preterm newborns developing retinopathy of prematurity (ROP) and bronchopulmonary dysplasia (BPD) show persistently low levels of insulin-like growth factor-I (IGF-I) in sera. They also present higher free IGF-I concentrations in epithelial lining fluids (ELFs) and lung tissues. Pregnancy-associated plasma protein-A (PAPP-A) is a metalloproteinase that dissociates three binding proteins from the active form of IGF-I, namely free IGF-I. The present study analyzes the ELF concentrations of free IGF-I, PAPP-A, and their ratios in preterm newborns developing or not BPD, defined as O(2) dependence at 36 wk postmenstrual age. Bronchoalveolar lavage fluids of 41 infants (34 without and 7 with BPD) were analyzed on the 2nd and 4th day after birth. Infants developing BPD showed increased ELF free IGF-I and decreased PAPP-A concentrations on both days 2 and 4 compared with newborns without BPD. A nonsignificant trend between these 2 days was observed for free IGF-I (increasing) and PAPP-A (decreasing). On the same days, the free IGF-I-to-PAPP-A ratio was always significantly higher in patients developing BPD. These differences were more significant than those of IGF-I or PAPP-A when individually evaluated. A multivariate analysis confirmed the significance for free IGF-I on day 4, whereas the ratio was confirmed on both days 2 and 4. The same ratio was significantly correlated with some indexes of disease severity, such as hours of oxygen administration, days of hospitalization, and ROP severity scores. Finally, the ratio between ELF free IGF-I and PAPP-A appears to be a useful marker for lung injury of premature newborns.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16954333     DOI: 10.1152/ajpendo.00251.2006

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  11 in total

1.  Role of distinct phospholipases A2 and their modulators in meconium aspiration syndrome in human neonates.

Authors:  Daniele De Luca; Angelo Minucci; Domenico Tripodi; Marco Piastra; Domenico Pietrini; Cecilia Zuppi; Giorgio Conti; Virgilio P Carnielli; Ettore Capoluongo
Journal:  Intensive Care Med       Date:  2011-05-13       Impact factor: 17.440

2.  A risk factor analysis on disease severity in 47 premature infants with bronchopulmonary dysplasia.

Authors:  Yan Li; Yazhou Cui; Chao Wang; Xiao Liu; Jinxiang Han
Journal:  Intractable Rare Dis Res       Date:  2015-05

3.  Bile acids cause secretory phospholipase A2 activity enhancement, revertible by exogenous surfactant administration.

Authors:  Daniele De Luca; Angelo Minucci; Enrico Zecca; Marco Piastra; Domenico Pietrini; Virgilio P Carnielli; Cecilia Zuppi; Ascanio Tridente; Giorgio Conti; Ettore D Capoluongo
Journal:  Intensive Care Med       Date:  2008-10-14       Impact factor: 17.440

4.  Mannose-binding lectin polymorphisms and pulmonary outcome in premature neonates: a pilot study.

Authors:  Ettore Capoluongo; Giovanni Vento; Sandro Rocchetti; Emiliano Giardina; Paola Concolino; Cecilia Sinibaldi; Concetta Santonocito; Valentina Vendettuoli; Milena Tana; Chiara Tirone; Cecilia Zuppi; Costantino Romagnoli; Giuseppe Novelli; Bruno Giardina; Franco Ameglio
Journal:  Intensive Care Med       Date:  2007-07-26       Impact factor: 17.440

5.  Secretory phospholipase A2 and neonatal respiratory distress: pilot study on broncho-alveolar lavage.

Authors:  Daniele De Luca; Silvia Baroni; Giovanni Vento; Marco Piastra; Domenico Pietrini; Federica Romitelli; Ettore Capoluongo; Costantino Romagnoli; Giorgio Conti; Enrico Zecca
Journal:  Intensive Care Med       Date:  2008-07-22       Impact factor: 17.440

6.  Secretory phospholipase A2 pathway in various types of lung injury in neonates and infants: a multicentre translational study.

Authors:  Daniele De Luca; Ettore Capoluongo; Vincent Rigo
Journal:  BMC Pediatr       Date:  2011-11-08       Impact factor: 2.125

7.  Clinical and biological role of secretory phospholipase A2 in acute respiratory distress syndrome infants.

Authors:  Daniele De Luca; Elena Lopez-Rodriguez; Angelo Minucci; Francesca Vendittelli; Leonarda Gentile; Eleonora Stival; Giorgio Conti; Marco Piastra; Massimo Antonelli; Mercedes Echaide; Jesus Perez-Gil; Ettore D Capoluongo
Journal:  Crit Care       Date:  2013-07-24       Impact factor: 9.097

8.  Ex vivo effect of varespladib on secretory phospholipase A2 alveolar activity in infants with ARDS.

Authors:  Daniele De Luca; Angelo Minucci; Marco Piastra; Paola E Cogo; Francesca Vendittelli; Laura Marzano; Leonarda Gentile; Bruno Giardina; Giorgio Conti; Ettore D Capoluongo
Journal:  PLoS One       Date:  2012-10-11       Impact factor: 3.240

9.  Low postnatal serum IGF-I levels are associated with bronchopulmonary dysplasia (BPD).

Authors:  Chatarina Löfqvist; Gunnel Hellgren; Aimon Niklasson; Eva Engström; David Ley; Ingrid Hansen-Pupp
Journal:  Acta Paediatr       Date:  2012-09-10       Impact factor: 2.299

Review 10.  Insulin-Like Growth Factor-1 Signaling in Lung Development and Inflammatory Lung Diseases.

Authors:  Zheng Wang; Wenting Li; Qiongya Guo; Yuming Wang; Lijun Ma; Xiaoju Zhang
Journal:  Biomed Res Int       Date:  2018-06-19       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.